- Global Pharma News & Resources

United States Obesity Market and Competitive Landscape Report 2018 -

The "US Obesity Market and Competitive Landscape - 2018" report has been added to's offering.

US Obesity Market and Competitive Landscape - 2018, provides comprehensive insights into Obesity pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Obesity market size and drug sales. This research also provides insights into Obesity epidemiology and late stage pipeline.

The research is classified into following sections - Obesity overview with definitions, symptoms, etiology, diagnosis, treatment options; Obesity pipeline insights covering late stage clinical trials pipeline; Obesity prevalence trends by countries; Obesity market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

  • Obesity pipeline: Find out the drugs in clinical trials for Obesity by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Obesity epidemiology: Find out the prevalence of Obesity in US; prevalence forecast to 2023
  • Obesity products: Identify key products marketed and prescribed for Obesity by brand name, by molecule, by company, by branded / generic, in US
  • Obesity market size: Find out the market size for Obesity drugs in US; Find out how the market advanced from 2014
  • Obesity drug sales: Find out the sales of Obesity drugs in US
  • Obesity drugs sales forecast: Sales forecast for Obesity drugs to 2023 in US
  • Obesity market share analysis: Find out the market shares of Obesity drugs and outlook in US

For more information about this report visit

View source version on

Editor Details

Last Updated: 02-Nov-2018